ATE208792T1 - Modifizierte biolumineszierende proteine und deren verwendung - Google Patents

Modifizierte biolumineszierende proteine und deren verwendung

Info

Publication number
ATE208792T1
ATE208792T1 AT90910819T AT90910819T ATE208792T1 AT E208792 T1 ATE208792 T1 AT E208792T1 AT 90910819 T AT90910819 T AT 90910819T AT 90910819 T AT90910819 T AT 90910819T AT E208792 T1 ATE208792 T1 AT E208792T1
Authority
AT
Austria
Prior art keywords
analyte
interaction site
bioluminescent
produced
bioluminescent proteins
Prior art date
Application number
AT90910819T
Other languages
English (en)
Inventor
Anthony Keith Maillar Campbell
Original Assignee
Univ Wales Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wales Medicine filed Critical Univ Wales Medicine
Application granted granted Critical
Publication of ATE208792T1 publication Critical patent/ATE208792T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43595Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AT90910819T 1989-07-22 1990-07-23 Modifizierte biolumineszierende proteine und deren verwendung ATE208792T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898916806A GB8916806D0 (en) 1989-07-22 1989-07-22 Modified proteins
PCT/GB1990/001131 WO1991001305A1 (en) 1989-07-22 1990-07-23 Modified bioluminescent proteins and their use

Publications (1)

Publication Number Publication Date
ATE208792T1 true ATE208792T1 (de) 2001-11-15

Family

ID=10660479

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90910819T ATE208792T1 (de) 1989-07-22 1990-07-23 Modifizierte biolumineszierende proteine und deren verwendung

Country Status (10)

Country Link
EP (2) EP1097992A3 (de)
JP (2) JP3375337B2 (de)
AT (1) ATE208792T1 (de)
AU (1) AU6054590A (de)
CA (1) CA2064766A1 (de)
DE (1) DE69033855T2 (de)
DK (1) DK0484369T3 (de)
ES (1) ES2167307T3 (de)
GB (1) GB8916806D0 (de)
WO (1) WO1991001305A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2666561B2 (ja) * 1990-03-27 1997-10-22 キッコーマン株式会社 変異型ホタルルシフェラーゼ、変異型ホタルルシフェラーゼ遺伝子、新規な組み換え体dna及び変異型ホタルルシフェラーゼの製造法
GB9126650D0 (en) * 1991-12-16 1992-02-12 Creighton Andrew M Further improvements relating to the radiolabelling of proteins
EP0759170B1 (de) * 1993-09-10 2008-07-09 The Trustees Of Columbia University In The City Of New York Verwendung von grünem fluoreszenzprotein
US6217847B1 (en) 1994-07-01 2001-04-17 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
US7255851B2 (en) 1994-07-01 2007-08-14 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
US5650135A (en) * 1994-07-01 1997-07-22 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
IL115177A0 (en) * 1994-09-16 1995-12-31 Immunomedics Inc Phosphorus-32 labeling of antibodies for cancer therapy
US5777079A (en) * 1994-11-10 1998-07-07 The Regents Of The University Of California Modified green fluorescent proteins
US5625048A (en) 1994-11-10 1997-04-29 The Regents Of The University Of California Modified green fluorescent proteins
US5958713A (en) * 1995-01-31 1999-09-28 Novo Nordisk A/S Method of detecting biologically active substances by using green fluorescent protein
GB9504446D0 (en) * 1995-03-06 1995-04-26 Medical Res Council Improvements in or relating to gene expression
EP1820517A3 (de) * 1995-11-17 2009-10-21 The Board Of Trustees Of The Leland Stanford Junior University Nichtinvasive Lokalisierung eines lichtemittierenden Konjugats bei einem Säugetier
US6900304B2 (en) 1996-01-31 2005-05-31 The Regents Of The University Of California Emission ratiometric indicators of phosphorylation
US6803188B1 (en) * 1996-01-31 2004-10-12 The Regents Of The University Of California Tandem fluorescent protein constructs
US8349602B1 (en) 1996-04-19 2013-01-08 Xenogen Corporation Biodetectors targeted to specific ligands
WO1998002571A1 (en) * 1996-07-16 1998-01-22 The Regents Of The University Of California Assays for protein kinases using fluorescent protein substrates
US5912137A (en) * 1996-07-16 1999-06-15 The Regents Of The University Of California Assays for protein kinases using fluorescent
US5925558A (en) * 1996-07-16 1999-07-20 The Regents Of The University Of California Assays for protein kinases using fluorescent protein substrates
US6124128A (en) * 1996-08-16 2000-09-26 The Regents Of The University Of California Long wavelength engineered fluorescent proteins
US6593135B2 (en) 1996-08-16 2003-07-15 The State Of Oregon, Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon Long wavelength engineered fluorescent proteins
US5976796A (en) * 1996-10-04 1999-11-02 Loma Linda University Construction and expression of renilla luciferase and green fluorescent protein fusion genes
US5998204A (en) * 1997-03-14 1999-12-07 The Regents Of The University Of California Fluorescent protein sensors for detection of analytes
US6197928B1 (en) 1997-03-14 2001-03-06 The Regents Of The University Of California Fluorescent protein sensors for detection of analytes
DE69804446T3 (de) 1997-04-07 2006-08-24 Bioimage A/S Verfahren um quantitativen informationen über einflüsse auf zelluläre reaktionen zu entnehmen
US6046925A (en) * 1997-04-14 2000-04-04 The Regents Of The University Of California Photochromic fluorescent proteins and optical memory storage devices based on fluorescent proteins
FR2764387B1 (fr) 1997-06-05 1999-07-23 Centre Nat Rech Scient Utilisation d'une proteine fluorescente pour la detection d'interactions entre une proteine cible et son ligand
DE19737562A1 (de) * 1997-08-28 1999-05-06 Otogene Biotechnologische Fors Verfahren zur Identifizierung von Wechselwirkungen zwischen Proteinen bzw. Peptiden
US6495664B1 (en) 1998-07-24 2002-12-17 Aurora Biosciences Corporation Fluorescent protein sensors of post-translational modifications
EP0984070A1 (de) * 1998-08-31 2000-03-08 Boehringer Ingelheim International GmbH Verfahren zur Auffindung von Verbindungen für die Behandlung von Krankheiten die assoziert sind mit C-Jun vermittelte Apoptosis
EP1121593A2 (de) * 1998-10-15 2001-08-08 BioImage A/S Verfahren zur ableitung quantitativer informationen über einen einfluss auf eine zelluläre respons
JP2003526608A (ja) * 1998-10-15 2003-09-09 バイオイメージ エイ/エス 再分布及び/又は標的化での干渉によって得られる特異的治療の介入
US6410255B1 (en) 1999-05-05 2002-06-25 Aurora Biosciences Corporation Optical probes and assays
US6573059B1 (en) * 1999-06-04 2003-06-03 Rmf Dictagene S.A. Use of the regulatory subunit of the camp dependent protein kinase (PKA) from dictyostelium for camp measurements
JP5389307B2 (ja) * 2000-06-01 2014-01-15 インスティチュート・パスツール 単細胞レベルでの生物発光性Ca++リポーターとしてのキメラ性GFP−エクオリン
JP3829252B2 (ja) 2001-06-08 2006-10-04 独立行政法人理化学研究所 蛍光蛋白質
US20050214734A1 (en) * 2002-04-01 2005-09-29 Seishi Kato Cell population provided with identification codes and method of screening cell population
CA2445420A1 (en) 2003-07-29 2005-01-29 Invitrogen Corporation Kinase and phosphatase assays
US7619059B2 (en) 2003-07-29 2009-11-17 Life Technologies Corporation Bimolecular optical probes
DE10342670A1 (de) * 2003-09-16 2005-04-21 Bayer Healthcare Ag Isoliertes Photoprotein mtClytin, sowie dessen Verwendung
CA2541765A1 (en) 2003-10-10 2004-10-01 Promega Corporation Luciferase biosensor
JP2005120005A (ja) * 2003-10-16 2005-05-12 Sekisui Chem Co Ltd 有機蛍光物質及び有機蛍光物質の製造方法
EP2327768B1 (de) 2006-04-03 2015-09-09 Promega Corporation Permutierte und nichtpermutierte Luciferase-Biosensoren
WO2009142735A2 (en) 2008-05-19 2009-11-26 Promega Corporation LUCIFERASE BIOSENSORS FOR cAMP
US8735559B2 (en) 2010-05-11 2014-05-27 Promega Corporation Mutant protease biosensors with enhanced detection characteristics
US9290794B2 (en) 2010-05-11 2016-03-22 Promega Corporation Mutant protease biosensors with enhanced detection characteristics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0103469B1 (de) * 1982-09-10 1989-02-08 The Welsh National School of Medicine Immunologisches Verfahren zur Bestimmung von Stoffen
DK487784A (da) * 1983-10-13 1985-04-14 Univ Georgia Immunoassay
JPS6439990A (en) * 1987-08-05 1989-02-10 Chisso Corp Fused gene by bonding aequorin gene to functional gene

Also Published As

Publication number Publication date
EP1097992A2 (de) 2001-05-09
JP3375337B2 (ja) 2003-02-10
EP0484369A1 (de) 1992-05-13
DK0484369T3 (da) 2002-03-11
JP2003102491A (ja) 2003-04-08
DE69033855D1 (de) 2001-12-20
EP0484369B1 (de) 2001-11-14
DE69033855T2 (de) 2002-07-11
AU6054590A (en) 1991-02-22
EP1097992A3 (de) 2001-05-16
WO1991001305A1 (en) 1991-02-07
ES2167307T3 (es) 2002-05-16
JPH05501862A (ja) 1993-04-08
GB8916806D0 (en) 1989-09-06
CA2064766A1 (en) 1991-01-23

Similar Documents

Publication Publication Date Title
ATE208792T1 (de) Modifizierte biolumineszierende proteine und deren verwendung
DE69833118D1 (de) Immunoassay zum bestimmen von bnp
ATE171163T1 (de) Homobidentale, trifunktionelle maleinimid-linker, und ihre verwendung in immunologisch aktiven konjugaten
DK0897983T3 (da) Antistoffer mod CD40-L
DE3776113D1 (de) Steuerbare scheibe.
DE122004000025I2 (de) Borons{ure-und-esterverbindungen, deren Systhese und Verwendungen
DE69133472D1 (de) Antikörper und ihre therapeutische Verwendung
DK0418355T3 (da) Fremgangsmåde til immobilisering af proteiner, peptider, coenzymer, etc. på et substrat
DE69133521D1 (de) Verwendung von vernetzten Kristallen als neue Form von Immobilisierung von Enzymen
ATE196162T1 (de) Toxoplasma gondii-antigene, ihre herstellung und ihre verwendung
CY1110438T1 (el) Χιμαιρικες (πρωτεϊνες συντηξης) gfp-ακουορινης ως βιοφωταυγεις αναφορεις ca++ στο επιπεδο του ενος κυτταρου
ATE160222T1 (de) Photoaktivierung von proteinen zu konjugationszwecken
FI954029A0 (fi) Kemiluminesoiva reagenssi ja analyysimenetelmä, jossa käytetään substituoitua asetanilidia valon muodostukseen
DE3683953D1 (de) Konjugate von glucose-6-phosphat-dehydrogenase, ihre herstellung und verwendung.
DK5982A (da) Fremgangsmaade til fremstilling af immunoglobulinkonjagater
DK0805692T3 (da) Aktiveringsstyrkelse af "biologiske" vævsadhæsiver, bindemidler og forseglinger under anvendelse af "farveændrende" kromoforer
DE69232669D1 (de) Mit gp11b/iiia reaktive humane antikörper
DE69120452D1 (de) Verwendung und Verabreichung von Enzymen
ATE52251T1 (de) Histamin-derivate, immunogen-konjugate und dadurch induzierte antikoerper.
DE3787776D1 (de) Pyruvat-Oxidase mit hoher thermischer Stabilität, diese verwendendes analytisches Verfahren und diese enthaltende analytische Reagenzien.
MX9401137A (es) Preparacion de sal de sodio de 1-amino-1-cianamido-2, 2-dicianoetileno.
ES2096596T3 (es) Procedimiento para la determinacion inmunologica de ligandos.
TW363986B (en) A process for producing polyparahydroxy styrene derivatives
DE59708051D1 (de) Stabilisierung von Standardlösungen durch Konjugate
DK0643041T3 (da) Fremgangsmåde til fremstilling af isocyansyre ud fre cyanursyre

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee